Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 462
Filter
Add more filters

Publication year range
1.
Clin Immunol ; 200: 66-70, 2019 03.
Article in English | MEDLINE | ID: mdl-30711607

ABSTRACT

In Pompe disease, anti-drug antibodies (ADA) to acid alpha-glucosidase (GAA) enzyme replacement therapy contribute to early mortality. Assessing individual risk for ADA development is notoriously difficult in (CRIM-positive) patients expressing endogenous GAA. The individualized T cell epitope measure (iTEM) scoring method predicts patient-specific risk of developing ADA against therapeutic recombinant human GAA (rhGAA) using individualized HLA-binding predictions and GAA genotype. CRIM-negative patients were six times more likely to develop high ADA titers than CRIM-positive patients in this retrospective study, whereas patients with high GAA-iTEM scores were 50 times more likely to develop high ADA titers than patients with low GAA-iTEM scores. This approach identifies high-risk IOPD patients requiring immune tolerance induction therapy to prevent significant ADA response to rhGAA leading to a poor clinical outcome and can assess ADA risk in patients receiving replacement therapy for other enzyme or blood factor deficiency disorders.


Subject(s)
Antibodies/immunology , Enzyme Replacement Therapy , Glycogen Storage Disease Type II/genetics , HLA-DRB1 Chains/genetics , alpha-Glucosidases/genetics , alpha-Glucosidases/immunology , Computer Simulation , Cross Reactions/immunology , Epitope Mapping , Epitopes, T-Lymphocyte/immunology , Glycogen Storage Disease Type II/drug therapy , Humans , Immune Tolerance/immunology , Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/therapeutic use , Infant , Methotrexate/therapeutic use , Recombinant Proteins , Risk Assessment , Rituximab/therapeutic use , alpha-Glucosidases/therapeutic use
2.
Breast Cancer Res Treat ; 176(1): 27-36, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30997625

ABSTRACT

PURPOSE: In breast cancer, hormone receptor (HR) status is generally a qualitative measure; positive or negative. Quantitatively measured oestrogen and progesterone receptors (ER and PR) are frequently proposed prognostic and predictive markers, some guidelines even provide different treatment options for patients with strong versus weak expression. AIM: To evaluate quantitative HR load assessed by immunohistochemistry as a prognostic and predictive measure in stage 1-3 breast cancer. METHODS: We reviewed all the available literature on quantitatively measured HRs using immunohistochemistry. RESULTS: All included studies (n = 19) comprised a cohort of 30,754 patients. Only 2 out of 17 studies found a clear correlation between higher quantitative ER and better disease outcome. Only one trial examined quantitative ER both as prognostic and predictive marker and found no association between ER% and survival. Ten studies examined quantitative PR load, only two of those found a significant correlation between higher PR load and better disease outcome. Two trials examined quantitative PR both as prognostic and predictive marker, neither found any association between PR% and disease outcome. CONCLUSIONS: There is no clear evidence for using quantitatively assessed ER and PR as prognostic nor predictive marker in patients with stage 1-3 breast cancer. We recommend only using a qualitative HR status in future guidelines and treatment considerations.


Subject(s)
Biomarkers, Tumor , Breast Neoplasms/metabolism , Breast Neoplasms/mortality , Receptors, Estrogen/metabolism , Breast Neoplasms/diagnosis , Breast Neoplasms/therapy , Combined Modality Therapy , Female , Humans , Mastectomy , Neoplasm Staging , Prognosis , Receptor, ErbB-2/metabolism , Receptors, Progesterone/metabolism , Treatment Outcome
3.
Breast Cancer Res Treat ; 175(3): 605-615, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30868392

ABSTRACT

PURPOSE: Tumor-infiltrating lymphocytes (TILs) are associated with pathological complete response (pCR) and survival after neoadjuvant chemotherapy (NAC) in patients with early breast cancer. We investigated the prognostic and predictive role of TILs, macrophages, and HLA class 1 expression after NAC with or without the potentially immune modulating compound zoledronic acid (ZA). METHODS: Baseline tumor biopsies from 196 patients in the NEOZOTAC trial were analyzed for CD8 (cytotoxic T-cells), FoxP3 (regulatory T-cells), CD68 (macrophages), and HLA class I (HCA2/HC10) expression by immunohistochemistry and subsequently related to pCR and disease-free survival (DFS). RESULTS: A strong intratumoral CD8+ infiltration or expression of HLA class 1 by cancer cells was associated with a higher pCR rate (p < 0.05). Clinical benefit of high CD8+ T-cell infiltration was found when cancer cells expressed HLA class 1 (pCR: 21.8% vs. 6.7%, p = 0.04) but not when HLA class 1 expression was lost or downregulated (pCR: 5.9% vs. 0%, p = 0.38). Interaction analyses revealed survival benefit between HLA class 1 expression and strong CD8+ T-cell infiltration, whereas in the absence or downregulation of HLA class 1 expression, high levels of CD8+ T-cells were associated with survival disadvantage (p for interaction 0.01; hazard ratio 0.41, 95% CI 0.15-1.10, p = 0.08 and hazard ratio 7.67, 95% CI 0.88-66.4, p = 0.07, respectively). Baseline immune markers were not related to ZA treatment. CONCLUSIONS: Strong baseline tumor infiltration with CD8+ T-cells in the presence of tumoral HLA class 1 expression in patients with HER2-negative breast cancer is related to a higher pCR rate and a better DFS after NAC.


Subject(s)
Breast Neoplasms/drug therapy , CD8-Positive T-Lymphocytes/immunology , Drug Therapy/methods , Histocompatibility Antigens Class I/metabolism , Lymphocytes, Tumor-Infiltrating/immunology , Zoledronic Acid/therapeutic use , Aged , Breast Neoplasms/immunology , Clinical Trials, Phase III as Topic , Disease-Free Survival , Female , Humans , Middle Aged , Neoadjuvant Therapy , Prognosis , Randomized Controlled Trials as Topic , Survival Analysis , Treatment Outcome , Tumor Microenvironment
4.
J Immunol ; 199(4): 1418-1428, 2017 08 15.
Article in English | MEDLINE | ID: mdl-28710255

ABSTRACT

Activation of the immune system needs to be tightly regulated to provide protection against infections and, at the same time, to prevent excessive inflammation to limit collateral damage to the host. This tight regulation includes regulating the activation of TLRs, which are key players in the recognition of invading microbes. A group of short cationic antimicrobial peptides, called cathelicidins, have previously been shown to modulate TLR activation by synthetic or purified TLR ligands and may play an important role in the regulation of inflammation during infections. However, little is known about how these cathelicidins affect TLR activation in the context of complete and viable bacteria. In this article, we show that chicken cathelicidin-2 kills Escherichia coli in an immunogenically silent fashion. Our results show that chicken cathelicidin-2 kills E. coli by permeabilizing the bacterial inner membrane and subsequently binds the outer membrane-derived lipoproteins and LPS to inhibit TLR2 and TLR4 activation, respectively. In addition, other cathelicidins, including human, mouse, pig, and dog cathelicidins, which lack antimicrobial activity under cell culture conditions, only inhibit macrophage activation by nonviable E. coli In total, this study shows that cathelicidins do not affect immune activation by viable bacteria and only inhibit inflammation when bacterial viability is lost. Therefore, cathelicidins provide a novel mechanism by which the immune system can discriminate between viable and nonviable Gram-negative bacteria to tune the immune response, thereby limiting collateral damage to the host and the risk for sepsis.


Subject(s)
Antimicrobial Cationic Peptides/physiology , Blood Proteins/physiology , Escherichia coli/immunology , Gram-Negative Bacteria/immunology , Macrophage Activation , Microbial Viability , Protein Precursors/physiology , Toll-Like Receptor 2/immunology , Toll-Like Receptor 4/immunology , Animals , Blood Proteins/isolation & purification , Blood Proteins/metabolism , Cathelicidins/physiology , Chickens/immunology , Dogs , Gram-Negative Bacteria/physiology , Humans , Inflammation/immunology , Mice , Protein Precursors/isolation & purification , Protein Precursors/metabolism , Swine/immunology
5.
Neth Heart J ; 24(2): 127-33, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26758507

ABSTRACT

BACKGROUND: The clinical course of bicuspid aortic valves (BAVs) is variable. Data on predictors of aortopathy and valvular dysfunction mainly focus on valve morphology. AIM: To determine whether the presence and extent of the raphe (fusion site of valve leaflets) is associated with the degree of aortopathy and valvular dysfunction in patients with isolated BAV and associated aortic coarctation (CoA). METHODS: Valve morphology and aortic dimensions of 255 BAV patients were evaluated retrospectively by echocardiography. RESULTS: BAVs with a complete raphe had a significantly higher prevalence of valve dysfunction (especially aortic regurgitation) than BAVs with incomplete raphes (82.9 vs. 66.7 %, p = 0.01). Type 1A BAVs (fusion of right and left coronary leaflets) and complete raphe had larger aortic sinus diameters compared with the rest of the population (37.74 vs. 36.01, p = 0.031). Patients with CoA and type 1A BAV had significantly less valve regurgitation (13.6 vs. 55.8 %, p < 0.001) and smaller diameters of the ascending aorta (33.7 vs. 37.8 mm, p < 0.001) and aortic arch (25.8 vs. 30.2 mm, p < 0.001) than patients with isolated BAV. CONCLUSIONS: Type 1A BAV with complete raphe is associated with more aortic regurgitation and root dilatation. The majority of CoA patients have incomplete raphes, associated with smaller aortic root diameters and less valve regurgitation.

6.
Pediatr Cardiol ; 36(1): 89-95, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25070391

ABSTRACT

The degree of right ventricular outflow tract obstruction, pulmonary stenosis (PS) and the development of major aorto-pulmonary collateral arteries (MAPCAs) in patients with tetralogy of Fallot (TOF) is related to clinical outcome. Vegf120/120 mutant mouse embryos develop TOF with various degrees of PS, comparable to humans. We aimed to study the ontogeny of the development of MAPCAs in this mouse model. The development of the right ventricular outflow tract, pulmonary arteries, and ductus arteriosus (DA) and formation of MAPCAs were studied in both wild type as well as Vegf120/120 mice from embryonic day 10.5 until day 19.5. Of the 49 Vegf120/120 embryos, 35 embryos (71%) had ventral displacement of the outflow tract and a subaortic ventricular septal defect. A time-related development in severity of PS to pulmonary atresia (PA) was observed. From embryonic day 12.5, hypoplasia of the DA was seen in 13 (37%) and absent DA in 12 (37%) of these embryos. The 3 (6%) embryos with PA and absent DA developed MAPCAs, after day 15.5. In all, the MAPCAs arose from both subclavian arteries, running posterior in the thoracic cavity, along the vagal nerve. The MAPCAs connected the pulmonary arteries at the site of the hilus. A time-related development of PS to PA can lead, in combination with absent DA, to the development of MAPCAs later in embryonic life as an alternative route for pulmonary perfusion in this mouse model. This finding contributes to a better understanding of the consecutive morphological changes in the development toward MAPCAs in humans.


Subject(s)
Collateral Circulation/physiology , Disease Models, Animal , Tetralogy of Fallot/embryology , Animals , Mice , Pulmonary Atresia/embryology , Vascular Endothelial Growth Factor A
7.
Neurobiol Dis ; 71: 245-59, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25151644

ABSTRACT

Vascular endothelial growth factor-A (VEGF-A) is best known as a key regulator of the formation of new blood vessels. Neutralization of VEGF-A with anti-VEGF therapy e.g. bevacizumab, can be painful, and this is hypothesized to result from a loss of VEGF-A-mediated neuroprotection. The multiple vegf-a gene products consist of two alternatively spliced families, typified by VEGF-A165a and VEGF-A165b (both contain 165 amino acids), both of which are neuroprotective. Under pathological conditions, such as in inflammation and cancer, the pro-angiogenic VEGF-A165a is upregulated and predominates over the VEGF-A165b isoform. We show here that in rats and mice VEGF-A165a and VEGF-A165b have opposing effects on pain, and that blocking the proximal splicing event - leading to the preferential expression of VEGF-A165b over VEGF165a - prevents pain in vivo. VEGF-A165a sensitizes peripheral nociceptive neurons through actions on VEGFR2 and a TRPV1-dependent mechanism, thus enhancing nociceptive signaling. VEGF-A165b blocks the effect of VEGF-A165a. After nerve injury, the endogenous balance of VEGF-A isoforms switches to greater expression of VEGF-Axxxa compared to VEGF-Axxxb, through an SRPK1-dependent pre-mRNA splicing mechanism. Pharmacological inhibition of SRPK1 after traumatic nerve injury selectively reduced VEGF-Axxxa expression and reversed associated neuropathic pain. Exogenous VEGF-A165b also ameliorated neuropathic pain. We conclude that the relative levels of alternatively spliced VEGF-A isoforms are critical for pain modulation under both normal conditions and in sensory neuropathy. Altering VEGF-Axxxa/VEGF-Axxxb balance by targeting alternative RNA splicing may be a new analgesic strategy.


Subject(s)
Antibodies/therapeutic use , DNA, Recombinant/genetics , Neuralgia/metabolism , Neuralgia/therapy , RNA, Messenger/metabolism , Vascular Endothelial Growth Factor A , Animals , Antibodies/pharmacology , Benzofurans , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Ganglia, Spinal/cytology , Hyperalgesia/metabolism , Male , Mice , Mice, Transgenic , Neural Conduction/genetics , Pain Measurement , Pain Threshold/physiology , Quinolines , RNA, Messenger/genetics , Rats , Rats, Wistar , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/metabolism , TRPV Cation Channels/deficiency , TRPV Cation Channels/genetics , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/immunology , Vascular Endothelial Growth Factor A/metabolism
8.
Ultrasound Obstet Gynecol ; 44(5): 568-74, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24515626

ABSTRACT

OBJECTIVE: The differential insertion of the atrioventricular valves is the ultrasonographic representation of the more apical attachment of the tricuspid valve to the septum with respect to the mitral valve. A linear insertion is present when both valves form a linear continuum and has been suggested as a marker for atrioventricular septal defects (AVSDs). The objective of this study was to evaluate the anatomical substratum of differential and linear insertions of the atrioventricular valves in normal fetal hearts and fetal hearts with an AVSD. METHODS: The extent and position of the fibrous skeleton and attachment of the atrioventricular valves to the septum were studied in histological sections of 17 normal hearts and four hearts with an AVSD from 10 + 0 weeks' gestation to 3 days postpartum with various immunohistochemical tissue markers. In addition, spatiotemporal image correlation (STIC) volumes of 10 normal hearts and STIC volumes of eight hearts with an AVSD at 13 + 6 to 35 + 5 weeks' gestation were examined. RESULTS: The differential insertion of the atrioventricular valves was visible in normal hearts in the four-chamber plane immediately beneath the aorta, but nearer the diaphragm a linear insertion was found. In hearts with an AVSD, a linear appearance was observed in the four-chamber plane immediately beneath the aorta. Towards the diaphragm, however, first a differential insertion and, more caudally, a linear insertion was found. CONCLUSIONS: Both differential and linear insertions can be found in normal fetal hearts and fetal hearts with AVSD, depending on the plane in which the four-chamber view is visualized. Therefore, measurement of the differential insertion is likely to be useful only in experienced hands.


Subject(s)
Fetal Heart/diagnostic imaging , Heart Septal Defects/diagnostic imaging , Mitral Valve/diagnostic imaging , Tricuspid Valve/diagnostic imaging , Echocardiography, Four-Dimensional/methods , Echocardiography, Three-Dimensional/methods , Fetal Heart/anatomy & histology , Fetal Heart/pathology , Humans , Microscopy/methods , Mitral Valve/anatomy & histology , Mitral Valve/pathology , Reference Values , Tricuspid Valve/anatomy & histology , Tricuspid Valve/pathology , Ultrasonography, Prenatal/methods
9.
Neth Heart J ; 22(9): 363-9, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25074475

ABSTRACT

Dilation of the wall of the thoracic aorta can be found in patients with a tricuspid (TAV) as well as a bicuspid aortic valve (BAV) with and without a syndromic component. BAV is the most common congenital cardiovascular malformation, with a population prevalence of 0.5-2 %. The clinical course is often characterised by aneurysm formation and in some cases dissection. The non-dilated aortic wall is less well differentiated in all BAV as compared with TAV, thereby conferring inherent developmental susceptibility. Furthermore, a turbulent flow, caused by the inappropriate opening of the bicuspid valve, could accelerate the degenerative process in the aortic wall. However, not all patients with bicuspidy develop clinical complications during their life. We postulate that the increased vulnerability for aortic complications in a subset of patients with BAV is caused by a defect in the early development of the aorta and aortic valve. This review discusses histological and molecular genetic aspects of the normal and abnormal development of the aortic wall and semilunar valves. Aortopathy associated with BAV could be the result of a shared developmental defect during embryogenesis.

10.
J Biol Chem ; 287(38): 31939-47, 2012 Sep 14.
Article in English | MEDLINE | ID: mdl-22843727

ABSTRACT

Mycobacteria use the dedicated type VII protein secretion systems ESX-1 and ESX-5 to secrete virulence factors across their highly hydrophobic cell envelope. The substrates of these systems include the large mycobacterial PE and PPE protein families, which are named after their characteristic Pro-Glu and Pro-Pro-Glu motifs. Pathogenic mycobacteria secrete large numbers of PE/PPE proteins via the major export pathway, ESX-5. In addition, a few PE/PPE proteins have been shown to be exported by ESX-1. It is not known how ESX-1 and ESX-5 recognize their cognate PE/PPE substrates. In this work, we investigated the function of the cytosolic protein EspG(5), which is essential for ESX-5-mediated secretion in Mycobacterium marinum, but for which the role in secretion is not known. By performing protein co-purifications, we show that EspG(5) interacts with several PPE proteins and a PE/PPE complex that is secreted by ESX-5, but not with the unrelated ESX-5 substrate EsxN or with PE/PPE proteins secreted by ESX-1. Conversely, the ESX-1 paralogue EspG(1) interacted with a PE/PPE couple secreted by ESX-1, but not with PE/PPE substrates of ESX-5. Furthermore, structural analysis of the complex formed by EspG(5) and PE/PPE indicates that these proteins interact in a 1:1:1 ratio. In conclusion, our study shows that EspG(5) and EspG(1) interact specifically with PE/PPE proteins that are secreted via their own ESX systems and suggests that EspG proteins are specific chaperones for the type VII pathway.


Subject(s)
Bacterial Proteins/metabolism , Escherichia coli Proteins/chemistry , Molecular Chaperones/chemistry , Mycobacterium marinum/enzymology , Cloning, Molecular , Cytosol/metabolism , Escherichia coli/metabolism , Escherichia coli Proteins/metabolism , Genetic Complementation Test , Mass Spectrometry/methods , Models, Molecular , Molecular Chaperones/metabolism , Mycobacterium marinum/metabolism , Nickel/chemistry , Plasmids/metabolism , Protein Structure, Tertiary , Secretory Pathway , Tandem Mass Spectrometry/methods
11.
Tijdschr Gerontol Geriatr ; 44(4): 175-83, 2013 Sep.
Article in Dutch | MEDLINE | ID: mdl-23925661

ABSTRACT

In general older adults, even the oldest old are community dwelling and vital. However, vulnerability can silently or suddenly exist. Multidisciplinary assessment of health problems and disabilities is necessary to compose a comprehensive intervention program. In the Netherlands, a team specialised in elderly care accomplishes home-based assessments. In 2009 we conducted a case study aiming to describe the characteristics of the patients and the reasons for consultation. A total of 84 records were analysed. 60% of the clients were 85 years or older, 32% were living independently and 61% were residents in homes for elderly people. The majority of clients was female and living alone (widowed). Most clients had multiple issues and were referred for cognitive evaluation. During the process of assessment many underlying behavioural, emotional and social problems became manifest. These findings support that symptoms and complaints of frail elderly are complex. A systematic multidisciplinary approach enhances the dialogue with patients and caregivers to discuss their needs and their attitude towards care. More research, however, is necessary to evaluate the effectiveness of this intervention.


Subject(s)
Aging/psychology , Ambulatory Care/organization & administration , Frail Elderly , Geriatric Assessment/methods , Health Services Needs and Demand , Aged , Aged, 80 and over , Cognition Disorders/diagnosis , Cognition Disorders/psychology , Female , Health Status , Homes for the Aged , Humans , Interdisciplinary Communication , Male , Netherlands , Patient Care Team
12.
Dev Dyn ; 240(11): 2561-77, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22012595

ABSTRACT

The inhibitor of differentiation Id2 is expressed in mesoderm of the second heart field, which contributes myocardial and mesenchymal cells to the primary heart tube. The role of Id2 in cardiac development is insufficiently known. Heart development was studied in sequential developmental stages in Id2 wildtype and knockout mouse embryos. Expression patterns of Id2, MLC-2a, Nkx2.5, HCN4, and WT-1 were analyzed. Id2 is expressed in myocardial progenitor cells at the inflow and outflow tract, in the endocardial and epicardial lineage, and in neural crest cells. Id2 knockout embryos show severe cardiac defects including abnormal orientation of systemic and pulmonary drainage, abnormal myocardialization of systemic and pulmonary veins, hypoplasia of the sinoatrial node, large interatrial communications, ventricular septal defects, double outlet right ventricle, and myocardial hypoplasia. Our results indicate a role for Id2 in the second heart field contribution at both the arterial and the venous poles of the heart.


Subject(s)
Heart Defects, Congenital/genetics , Heart/embryology , Inhibitor of Differentiation Protein 2/genetics , Animals , Animals, Newborn , Body Patterning/genetics , Computer Simulation , Embryo, Mammalian , Gene Expression Regulation, Developmental , Gestational Age , Heart/anatomy & histology , Heart Defects, Congenital/embryology , Imaging, Three-Dimensional , Inhibitor of Differentiation Protein 2/metabolism , Mice , Mice, Knockout , Models, Biological , Organogenesis/genetics
13.
Appl Environ Microbiol ; 77(18): 6516-23, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21784920

ABSTRACT

Q fever, caused by Coxiella burnetii, is a zoonosis with a worldwide distribution. A large rural area in the southeast of the Netherlands was heavily affected by Q fever between 2007 and 2009. This initiated the development of a robust and internally controlled multiplex quantitative PCR (qPCR) assay for the detection of C. burnetii DNA in veterinary and environmental matrices on suspected Q fever-affected farms. The qPCR detects three C. burnetii targets (icd, com1, and IS1111) and one Bacillus thuringiensis internal control target (cry1b). Bacillus thuringiensis spores were added to samples to control both DNA extraction and PCR amplification. The performance of the qPCR assay was investigated and showed a high efficiency; a limit of detection of 13.0, 10.6, and 10.4 copies per reaction for the targets icd, com1, and IS1111, respectively; and no cross-reactivity with the nontarget organisms tested. Screening for C. burnetii DNA on 29 suspected Q fever-affected farms during the Q fever epidemic in 2008 showed that swabs from dust-accumulating surfaces contained higher levels of C. burnetii DNA than vaginal swabs from goats or sheep. PCR inhibition by coextracted substances was observed in some environmental samples, and 10- or 100-fold dilutions of samples were sufficient to obtain interpretable signals for both the C. burnetii targets and the internal control. The inclusion of an internal control target and three C. burnetii targets in one multiplex qPCR assay showed that complex veterinary and environmental matrices can be screened reliably for the presence of C. burnetii DNA during an outbreak.


Subject(s)
Bacteriological Techniques/methods , Coxiella burnetii/isolation & purification , Disease Outbreaks , Environmental Microbiology , Multiplex Polymerase Chain Reaction/methods , Q Fever/veterinary , Real-Time Polymerase Chain Reaction/methods , Animals , Animals, Domestic , Bacillus thuringiensis/genetics , Bacteriological Techniques/standards , Coxiella burnetii/genetics , Female , Goats , Multiplex Polymerase Chain Reaction/standards , Netherlands/epidemiology , Q Fever/epidemiology , Q Fever/microbiology , Real-Time Polymerase Chain Reaction/standards , Sensitivity and Specificity , Sheep , Vagina/microbiology
14.
Ann Rheum Dis ; 69 Suppl 1: i72-76, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19995750

ABSTRACT

Monoclonal antibodies have proved to be extremely valuable additions to conventional treatment for rheumatic diseases. However, despite the general trend towards "humanisation", these drugs remain immunogenic in clinical settings, baffling drug developers. In principle, humanised and fully human monoclonal antibodies are "self" immunoglobulins and should be tolerated. In this overview, the factors that may influence this process, the nature of immunogenicity and methods to analyse and modify potential immunogenicity are discussed. Finally, novel approaches to "re-induce" immunological tolerance to these proteins, including gene therapy and the recognition of unique regulatory epitopes, are outlined.


Subject(s)
Antibodies, Monoclonal/immunology , Immune Tolerance , Antibodies, Monoclonal/therapeutic use , Drug Design , Epitopes, T-Lymphocyte/immunology , Genetic Therapy/methods , Humans
15.
Magn Reson Med ; 63(3): 817-21, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20187188

ABSTRACT

Recently, debate has arisen about the usefulness of cell tracking using iron oxide-labeled cells. Two important issues in determining the usefulness of cell tracking with MRI are generally overlooked; first, the effect of graft rejection in immunocompetent models, and second, the necessity for careful histological confirmation of the fate of the labeled cells in the presence of iron oxide. Therefore, both iron oxide-labeled living as well as dead epicardium-derived cells (EPDCs) were investigated in ischemic myocardium of immunodeficient non-obese diabetic (NOD)/acid: non-obese diabetic severe combined immunodeficient (NOD/scid) mice with 9.4T MRI until 6 weeks after surgery, at which time immunohistochemical analysis was performed. In both groups, voids on MRI scans were observed that did not change in number, size, or localization over time. Based on MRI, no distinction could be made between living and dead injected cells. Prussian blue staining confirmed that the hypointense spots on MRI corresponded to iron-loaded cells. However, in the dead-EPDC recipients, all iron-positive cells appeared to be macrophages, while the living-EPDC recipients also contained engrafted iron-loaded EPDCs. Iron labeling is inadequate for determining the fate of transplanted cells in the immunodeficient host, since dead cells produce an MRI signal indistinguishable from incorporated living cells.


Subject(s)
Ferric Compounds , Image Enhancement/methods , Magnetic Resonance Imaging/methods , Myocardial Infarction/pathology , Myocardial Infarction/surgery , Myocytes, Cardiac/pathology , Myocytes, Cardiac/transplantation , Cell Survival , Cells, Cultured , Contrast Media , Humans , Reproducibility of Results , Sensitivity and Specificity
16.
Sci Rep ; 10(1): 13311, 2020 08 07.
Article in English | MEDLINE | ID: mdl-32770104

ABSTRACT

Q-fever is a flu-like illness caused by Coxiella burnetii (Cb), a highly infectious intracellular bacterium. There is an unmet need for a safe and effective vaccine for Q-fever. Correlates of immune protection to Cb infection are limited. We proposed that analysis by longitudinal high dimensional immune (HDI) profiling using mass cytometry combined with other measures of vaccination and protection could be used to identify novel correlates of effective vaccination and control of Cb infection. Using a vaccine-challenge model in HLA-DR transgenic mice, we demonstrated significant alterations in circulating T-cell and innate immune populations that distinguished vaccinated from naïve mice within 10 days, and persisted until at least 35 days post-vaccination. Following challenge, vaccinated mice exhibited reduced bacterial burden and splenomegaly, along with distinct effector T-cell and monocyte profiles. Correlation of HDI data to serological and pathological measurements was performed. Our data indicate a Th1-biased response to Cb, consistent with previous reports, and identify Ly6C, CD73, and T-bet expression in T-cell, NK-cell, and monocytic populations as distinguishing features between vaccinated and naïve mice. This study refines the understanding of the integrated immune response to Cb vaccine and challenge, which can inform the assessment of candidate vaccines for Cb.


Subject(s)
Bacterial Vaccines/immunology , Coxiella burnetii/immunology , Immunity, Cellular , Immunity, Innate , Q Fever/prevention & control , T-Lymphocytes/immunology , Animals , Female , HLA-DR Antigens/genetics , HLA-DR Antigens/immunology , Humans , Killer Cells, Natural/immunology , Killer Cells, Natural/pathology , Mice , Mice, Inbred BALB C , Mice, Transgenic , Monocytes/immunology , Monocytes/pathology , Q Fever/genetics , Q Fever/immunology , Q Fever/pathology , T-Lymphocytes/pathology
17.
Science ; 154(3746): 270-1, 1966 Oct 14.
Article in English | MEDLINE | ID: mdl-5914760

ABSTRACT

Ingestion by hens and broilers of specific chloroanisols present in some wood shavings used in poultry cages can result in a musty taste in poultry products.


Subject(s)
Eggs , Meat , Poultry , Taste , Animals , Wood
18.
Tijdschr Psychiatr ; 51(10): 773-7, 2009.
Article in Dutch | MEDLINE | ID: mdl-19821246

ABSTRACT

BACKGROUND: This article focuses on two patients with psychiatric symptoms arising from systemic lupus erythematosus (SLE). Affective and psychotic symptoms frequently occur in SLE, often in combination with cognitive disturbances, and can be a first manifestation of the disorder. The diagnosis and treatment of a possible case of neuropsychiatric SLE should preferably take place in a multidisciplinary setting.


Subject(s)
Cognition Disorders/diagnosis , Lupus Erythematosus, Systemic/psychology , Mental Disorders/diagnosis , Adult , Cognition Disorders/etiology , Female , Humans , Lupus Erythematosus, Systemic/complications , Mental Disorders/etiology
20.
Circulation ; 116(8): 917-27, 2007 Aug 21.
Article in English | MEDLINE | ID: mdl-17684151

ABSTRACT

BACKGROUND: Proper development of compact myocardium, coronary vessels, and Purkinje fibers depends on the presence of epicardium-derived cells (EPDCs) in embryonic myocardium. We hypothesized that adult human EPDCs might partly reactivate their embryonic program when transplanted into ischemic myocardium and improve cardiac performance after myocardial infarction. METHODS AND RESULTS: EPDCs were isolated from human adult atrial tissue. Myocardial infarction was created in immunodeficient mice, followed by intramyocardial injection of 4x10(5) enhanced green fluorescent protein-labeled EPDCs (2-week survival, n=22; 6-week survival, n=15) or culture medium (n=24 and n=18, respectively). Left ventricular function was assessed with a 9.4T animal MRI unit. Ejection fraction was similar between groups on day 2 but was significantly higher in the EPDC-injected group at 2 weeks (short term), as well as after long-term survival at 6 weeks. End-systolic and end-diastolic volumes were significantly smaller in the EPDC-injected group than in the medium-injected group at all ages evaluated. At 2 weeks, vascularization was significantly increased in the EPDC-treated group, as was wall thickness, a development that might be explained by augmented DNA-damage repair activity in the infarcted area. Immunohistochemical analysis showed massive engraftment of injected EPDCs at 2 weeks, with expression of alpha-smooth muscle actin, von Willebrand factor, sarcoplasmic reticulum Ca2+-ATPase, and voltage-gated sodium channel (alpha-subunit; SCN5a). EPDCs were negative for cardiomyocyte markers. At 6-weeks survival, wall thickness was still increased, but only a few EPDCs could be detected. CONCLUSIONS: After transplantation into ischemic myocardium, adult human EPDCs preserve cardiac function and attenuate ventricular remodeling. Autologous human EPDCs are promising candidates for clinical application in infarcted hearts.


Subject(s)
Cell Transplantation/methods , Myocardial Infarction/therapy , Ventricular Dysfunction, Left/therapy , Ventricular Function, Left/physiology , Ventricular Remodeling/physiology , Animals , Body Weight , Cell Transplantation/mortality , Cells, Cultured , Humans , Magnetic Resonance Imaging , Mice , Mice, Inbred NOD , Mice, SCID , Myocardial Infarction/mortality , Myocardial Infarction/physiopathology , Pericardium/cytology , Transplantation, Heterologous , Ventricular Dysfunction, Left/mortality , Ventricular Dysfunction, Left/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL